Details
Transthyretin cardiac amyloidosis (ATTR-CA) is gaining more attention—but many patients are still diagnosed later than they should be.
At #ACC26, our partners @PeerView hosted a discussion with Drs. Sarah Cuddy and Vasvi Singh focused on how cardiology teams can better recognize and manage this complex condition in everyday practice.
From improving early detection to thinking differently about treatment approaches, this program offers a practical look at how care is evolving.